 | • レポートコード：QYR9ST09333 • 出版社/出版日：QYResearch / 2019年9月5日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥518,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,036,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、組換え血漿タンパク質治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、組換え凝固因子、ヒトC1エステラーゼ阻害剤に、用途別には、血友病A、血友病B、フォンウィルブランド病にセグメント区分し、組換え血漿タンパク質治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・組換え血漿タンパク質治療薬の世界市場概要 ・組換え血漿タンパク質治療薬の製造コスト構成分析 ・組換え血漿タンパク質治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・組換え血漿タンパク質治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・組換え血漿タンパク質治療薬のセグメント分析（種類別） （組換え凝固因子、ヒトC1エステラーゼ阻害剤） ・組換え血漿タンパク質治療薬のセグメント分析（用途別） （血友病A、血友病B、フォンウィルブランド病） ・組換え血漿タンパク質治療薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （CSL Limited、Shire、Octapharma、Novo Nordisk A/S、Pfizer、Bioverativ Therapeutics、Aptevo Therapeutics、Pharming Group） ・組換え血漿タンパク質治療薬の市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
Recombinant plasma protein therapeutics market is driven by various factors such as shift from use of plasma-derived proteins to recombinant therapies, rise in awareness about rare disease management and increased focus on investments in rare diseases.Rising demand from Asia-Pacific region is a major driver for the growth of the market.
The global Recombinant Plasma Protein Therapeutics market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Recombinant Plasma Protein Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Recombinant Plasma Protein Therapeutics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Recombinant Plasma Protein Therapeutics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Recombinant Plasma Protein Therapeutics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
CSL Limited
Shire
Octapharma
Novo Nordisk A/S
Pfizer
Bioverativ Therapeutics
Aptevo Therapeutics
Pharming Group
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Recombinant Coagulation Factors
Human C1 Esterase Inhibitor
Segment by Application
Hemophilia A
Hemophilia B
Von Willebrand Disease
Table of Contents
Executive Summary
1 Industry Overview of Recombinant Plasma Protein Therapeutics
1.1 Definition of Recombinant Plasma Protein Therapeutics
1.2 Recombinant Plasma Protein Therapeutics Segment by Type
1.2.1 Global Recombinant Plasma Protein Therapeutics Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Recombinant Coagulation Factors
1.2.3 Human C1 Esterase Inhibitor
1.3 Recombinant Plasma Protein Therapeutics Segment by Applications
1.3.1 Global Recombinant Plasma Protein Therapeutics Consumption Comparison by Applications (2014-2025)
1.3.2 Hemophilia A
1.3.3 Hemophilia B
1.3.4 Von Willebrand Disease
1.4 Global Recombinant Plasma Protein Therapeutics Overall Market
1.4.1 Global Recombinant Plasma Protein Therapeutics Revenue (2014-2025)
1.4.2 Global Recombinant Plasma Protein Therapeutics Production (2014-2025)
1.4.3 North America Recombinant Plasma Protein Therapeutics Status and Prospect (2014-2025)
1.4.4 Europe Recombinant Plasma Protein Therapeutics Status and Prospect (2014-2025)
1.4.5 China Recombinant Plasma Protein Therapeutics Status and Prospect (2014-2025)
1.4.6 Japan Recombinant Plasma Protein Therapeutics Status and Prospect (2014-2025)
1.4.7 Southeast Asia Recombinant Plasma Protein Therapeutics Status and Prospect (2014-2025)
1.4.8 India Recombinant Plasma Protein Therapeutics Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Recombinant Plasma Protein Therapeutics
2.3 Manufacturing Process Analysis of Recombinant Plasma Protein Therapeutics
2.4 Industry Chain Structure of Recombinant Plasma Protein Therapeutics
3 Development and Manufacturing Plants Analysis of Recombinant Plasma Protein Therapeutics
3.1 Capacity and Commercial Production Date
3.2 Global Recombinant Plasma Protein Therapeutics Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Recombinant Plasma Protein Therapeutics
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Recombinant Plasma Protein Therapeutics Production and Capacity Analysis
4.2 Recombinant Plasma Protein Therapeutics Revenue Analysis
4.3 Recombinant Plasma Protein Therapeutics Price Analysis
4.4 Market Concentration Degree
5 Recombinant Plasma Protein Therapeutics Regional Market Analysis
5.1 Recombinant Plasma Protein Therapeutics Production by Regions
5.1.1 Global Recombinant Plasma Protein Therapeutics Production by Regions
5.1.2 Global Recombinant Plasma Protein Therapeutics Revenue by Regions
5.2 Recombinant Plasma Protein Therapeutics Consumption by Regions
5.3 North America Recombinant Plasma Protein Therapeutics Market Analysis
5.3.1 North America Recombinant Plasma Protein Therapeutics Production
5.3.2 North America Recombinant Plasma Protein Therapeutics Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Recombinant Plasma Protein Therapeutics Import and Export
5.4 Europe Recombinant Plasma Protein Therapeutics Market Analysis
5.4.1 Europe Recombinant Plasma Protein Therapeutics Production
5.4.2 Europe Recombinant Plasma Protein Therapeutics Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Recombinant Plasma Protein Therapeutics Import and Export
5.5 China Recombinant Plasma Protein Therapeutics Market Analysis
5.5.1 China Recombinant Plasma Protein Therapeutics Production
5.5.2 China Recombinant Plasma Protein Therapeutics Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Recombinant Plasma Protein Therapeutics Import and Export
5.6 Japan Recombinant Plasma Protein Therapeutics Market Analysis
5.6.1 Japan Recombinant Plasma Protein Therapeutics Production
5.6.2 Japan Recombinant Plasma Protein Therapeutics Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Recombinant Plasma Protein Therapeutics Import and Export
5.7 Southeast Asia Recombinant Plasma Protein Therapeutics Market Analysis
5.7.1 Southeast Asia Recombinant Plasma Protein Therapeutics Production
5.7.2 Southeast Asia Recombinant Plasma Protein Therapeutics Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Recombinant Plasma Protein Therapeutics Import and Export
5.8 India Recombinant Plasma Protein Therapeutics Market Analysis
5.8.1 India Recombinant Plasma Protein Therapeutics Production
5.8.2 India Recombinant Plasma Protein Therapeutics Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Recombinant Plasma Protein Therapeutics Import and Export
6 Recombinant Plasma Protein Therapeutics Segment Market Analysis (by Type)
6.1 Global Recombinant Plasma Protein Therapeutics Production by Type
6.2 Global Recombinant Plasma Protein Therapeutics Revenue by Type
6.3 Recombinant Plasma Protein Therapeutics Price by Type
7 Recombinant Plasma Protein Therapeutics Segment Market Analysis (by Application)
7.1 Global Recombinant Plasma Protein Therapeutics Consumption by Application
7.2 Global Recombinant Plasma Protein Therapeutics Consumption Market Share by Application (2014-2019)
8 Recombinant Plasma Protein Therapeutics Major Manufacturers Analysis
8.1 CSL Limited
8.1.1 CSL Limited Recombinant Plasma Protein Therapeutics Production Sites and Area Served
8.1.2 CSL Limited Product Introduction, Application and Specification
8.1.3 CSL Limited Recombinant Plasma Protein Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Shire
8.2.1 Shire Recombinant Plasma Protein Therapeutics Production Sites and Area Served
8.2.2 Shire Product Introduction, Application and Specification
8.2.3 Shire Recombinant Plasma Protein Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Octapharma
8.3.1 Octapharma Recombinant Plasma Protein Therapeutics Production Sites and Area Served
8.3.2 Octapharma Product Introduction, Application and Specification
8.3.3 Octapharma Recombinant Plasma Protein Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Novo Nordisk A/S
8.4.1 Novo Nordisk A/S Recombinant Plasma Protein Therapeutics Production Sites and Area Served
8.4.2 Novo Nordisk A/S Product Introduction, Application and Specification
8.4.3 Novo Nordisk A/S Recombinant Plasma Protein Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Pfizer
8.5.1 Pfizer Recombinant Plasma Protein Therapeutics Production Sites and Area Served
8.5.2 Pfizer Product Introduction, Application and Specification
8.5.3 Pfizer Recombinant Plasma Protein Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Bioverativ Therapeutics
8.6.1 Bioverativ Therapeutics Recombinant Plasma Protein Therapeutics Production Sites and Area Served
8.6.2 Bioverativ Therapeutics Product Introduction, Application and Specification
8.6.3 Bioverativ Therapeutics Recombinant Plasma Protein Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Aptevo Therapeutics
8.7.1 Aptevo Therapeutics Recombinant Plasma Protein Therapeutics Production Sites and Area Served
8.7.2 Aptevo Therapeutics Product Introduction, Application and Specification
8.7.3 Aptevo Therapeutics Recombinant Plasma Protein Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Pharming Group
8.8.1 Pharming Group Recombinant Plasma Protein Therapeutics Production Sites and Area Served
8.8.2 Pharming Group Product Introduction, Application and Specification
8.8.3 Pharming Group Recombinant Plasma Protein Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
9 Development Trend of Analysis of Recombinant Plasma Protein Therapeutics Market
9.1 Global Recombinant Plasma Protein Therapeutics Market Trend Analysis
9.1.1 Global Recombinant Plasma Protein Therapeutics Market Size (Volume and Value) Forecast 2019-2025
9.2 Recombinant Plasma Protein Therapeutics Regional Market Trend
9.2.1 North America Recombinant Plasma Protein Therapeutics Forecast 2019-2025
9.2.2 Europe Recombinant Plasma Protein Therapeutics Forecast 2019-2025
9.2.3 China Recombinant Plasma Protein Therapeutics Forecast 2019-2025
9.2.4 Japan Recombinant Plasma Protein Therapeutics Forecast 2019-2025
9.2.5 Southeast Asia Recombinant Plasma Protein Therapeutics Forecast 2019-2025
9.2.6 India Recombinant Plasma Protein Therapeutics Forecast 2019-2025
9.3 Recombinant Plasma Protein Therapeutics Market Trend (Product Type)
9.4 Recombinant Plasma Protein Therapeutics Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Recombinant Plasma Protein Therapeutics Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of Recombinant Plasma Protein Therapeutics
Table Global Recombinant Plasma Protein Therapeutics Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Recombinant Plasma Protein Therapeutics Production Market Share by Types in 2018
Figure Recombinant Coagulation Factors Product Picture
Figure Human C1 Esterase Inhibitor Product Picture
Table Global Recombinant Plasma Protein Therapeutics Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Recombinant Plasma Protein Therapeutics Consumption Market Share by Applications in 2018
Figure Hemophilia A
Figure Hemophilia B
Figure Von Willebrand Disease
Figure Global Recombinant Plasma Protein Therapeutics Revenue (Million USD) (2014-2025)
Figure Global Recombinant Plasma Protein Therapeutics Production (K Units) (2014-2025)
Figure North America Recombinant Plasma Protein Therapeutics Market Size (Million USD) (2014-2025)
Figure Europe Recombinant Plasma Protein Therapeutics Market Size (Million USD) (2014-2025)
Figure China Recombinant Plasma Protein Therapeutics Market Size (Million USD) (2014-2025)
Figure Japan Recombinant Plasma Protein Therapeutics Market Size (Million USD) (2014-2025)
Figure Southeast Asia Recombinant Plasma Protein Therapeutics Market Size (Million USD) (2014-2025)
Figure India Recombinant Plasma Protein Therapeutics Market Size (Million USD) (2014-2025)
Table Recombinant Plasma Protein Therapeutics Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Recombinant Plasma Protein Therapeutics in 2018
Figure Manufacturing Process Analysis of Recombinant Plasma Protein Therapeutics
Figure Industry Chain Structure of Recombinant Plasma Protein Therapeutics
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Recombinant Plasma Protein Therapeutics Manufacturing Plants Distribution
Table Recombinant Plasma Protein Therapeutics Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Recombinant Plasma Protein Therapeutics Capacity (K Units) of Major Manufacturers (2014-2019)
Table Recombinant Plasma Protein Therapeutics Production (K Units) of Major Manufacturers (2014-2019)
Table Recombinant Plasma Protein Therapeutics Production Market Share of Major Manufacturers (2014-2019)
Figure Recombinant Plasma Protein Therapeutics Production Share by Manufacturers in 2018
Table Recombinant Plasma Protein Therapeutics Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Recombinant Plasma Protein Therapeutics Revenue Market Share of Major Manufacturers (2014-2019)
Figure Recombinant Plasma Protein Therapeutics Revenue Share by Manufacturers in 2018
Table Recombinant Plasma Protein Therapeutics Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Recombinant Plasma Protein Therapeutics Production by Regions 2014-2019 (K Units)
Table Global Recombinant Plasma Protein Therapeutics Production Market Share by Regions 2014-2019
Figure Global Recombinant Plasma Protein Therapeutics Production Market Share by Regions in 2018
Table Global Recombinant Plasma Protein Therapeutics Revenue by Regions 2014-2019 (Million USD)
Table Global Recombinant Plasma Protein Therapeutics Revenue Market Share by Regions 2014-2019
Figure Global Recombinant Plasma Protein Therapeutics Revenue Market Share by Regions in 2018
Table Global Recombinant Plasma Protein Therapeutics Consumption by Regions 2014-2019 (K Units)
Table Global Recombinant Plasma Protein Therapeutics Consumption Market Share by Regions 2014-2019
Figure North America Recombinant Plasma Protein Therapeutics Production Growth Rate 2014-2019 (K Units)
Figure North America Recombinant Plasma Protein Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table North America Recombinant Plasma Protein Therapeutics Production, Consumption Import and Export (K Units)
Figure Europe Recombinant Plasma Protein Therapeutics Production Growth Rate 2014-2019 (K Units)
Figure Europe Recombinant Plasma Protein Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Recombinant Plasma Protein Therapeutics Production, Consumption Import and Export (K Units)
Figure China Recombinant Plasma Protein Therapeutics Production Growth Rate 2014-2019 (K Units)
Figure China Recombinant Plasma Protein Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table China Recombinant Plasma Protein Therapeutics Production, Consumption Import and Export (K Units)
Figure Japan Recombinant Plasma Protein Therapeutics Production Growth Rate 2014-2019 (K Units)
Figure Japan Recombinant Plasma Protein Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Recombinant Plasma Protein Therapeutics Production, Consumption Import and Export (K Units)
Figure Southeast Asia Recombinant Plasma Protein Therapeutics Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Recombinant Plasma Protein Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Recombinant Plasma Protein Therapeutics Production, Consumption Import and Export (K Units)
Figure India Recombinant Plasma Protein Therapeutics Production Growth Rate 2014-2019 (K Units)
Figure India Recombinant Plasma Protein Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table India Recombinant Plasma Protein Therapeutics Production, Consumption Import and Export (K Units)
Figure Global Consumption Recombinant Plasma Protein Therapeutics Market Share by Application (2014-2019)
Figure Global Value (Consumption) Recombinant Plasma Protein Therapeutics Market Share by Application (2014-2019)
Table CSL Limited Recombinant Plasma Protein Therapeutics Production Sites and Area Served
Table CSL Limited Recombinant Plasma Protein Therapeutics Product Introduction, Application and Specification
Table CSL Limited Recombinant Plasma Protein Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table CSL Limited Recombinant Plasma Protein Therapeutics Production Growth Rate (2014-2019)
Table CSL Limited Recombinant Plasma Protein Therapeutics Production Market Share (2014-2019)
Figure CSL Limited Recombinant Plasma Protein Therapeutics Revenue Market Share (2014-2019)
Table CSL Limited Recombinant Plasma Protein Therapeutics Main Business and Markets Served
Table Shire Recombinant Plasma Protein Therapeutics Production Sites and Area Served
Table Shire Recombinant Plasma Protein Therapeutics Product Introduction, Application and Specification
Table Shire Recombinant Plasma Protein Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Shire Recombinant Plasma Protein Therapeutics Production Growth Rate (2014-2019)
Table Shire Recombinant Plasma Protein Therapeutics Production Market Share (2014-2019)
Figure Shire Recombinant Plasma Protein Therapeutics Revenue Market Share (2014-2019)
Table Shire Recombinant Plasma Protein Therapeutics Main Business and Markets Served
Table Octapharma Recombinant Plasma Protein Therapeutics Production Sites and Area Served
Table Octapharma Recombinant Plasma Protein Therapeutics Product Introduction, Application and Specification
Table Octapharma Recombinant Plasma Protein Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Octapharma Recombinant Plasma Protein Therapeutics Production Growth Rate (2014-2019)
Table Octapharma Recombinant Plasma Protein Therapeutics Production Market Share (2014-2019)
Figure Octapharma Recombinant Plasma Protein Therapeutics Revenue Market Share (2014-2019)
Table Octapharma Recombinant Plasma Protein Therapeutics Main Business and Markets Served
Table Novo Nordisk A/S Recombinant Plasma Protein Therapeutics Production Sites and Area Served
Table Novo Nordisk A/S Recombinant Plasma Protein Therapeutics Product Introduction, Application and Specification
Table Novo Nordisk A/S Recombinant Plasma Protein Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Novo Nordisk A/S Recombinant Plasma Protein Therapeutics Production Growth Rate (2014-2019)
Table Novo Nordisk A/S Recombinant Plasma Protein Therapeutics Production Market Share (2014-2019)
Figure Novo Nordisk A/S Recombinant Plasma Protein Therapeutics Revenue Market Share (2014-2019)
Table Novo Nordisk A/S Recombinant Plasma Protein Therapeutics Main Business and Markets Served
Table Pfizer Recombinant Plasma Protein Therapeutics Production Sites and Area Served
Table Pfizer Recombinant Plasma Protein Therapeutics Product Introduction, Application and Specification
Table Pfizer Recombinant Plasma Protein Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recombinant Plasma Protein Therapeutics Production Growth Rate (2014-2019)
Table Pfizer Recombinant Plasma Protein Therapeutics Production Market Share (2014-2019)
Figure Pfizer Recombinant Plasma Protein Therapeutics Revenue Market Share (2014-2019)
Table Pfizer Recombinant Plasma Protein Therapeutics Main Business and Markets Served
Table Bioverativ Therapeutics Recombinant Plasma Protein Therapeutics Production Sites and Area Served
Table Bioverativ Therapeutics Recombinant Plasma Protein Therapeutics Product Introduction, Application and Specification
Table Bioverativ Therapeutics Recombinant Plasma Protein Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Bioverativ Therapeutics Recombinant Plasma Protein Therapeutics Production Growth Rate (2014-2019)
Table Bioverativ Therapeutics Recombinant Plasma Protein Therapeutics Production Market Share (2014-2019)
Figure Bioverativ Therapeutics Recombinant Plasma Protein Therapeutics Revenue Market Share (2014-2019)
Table Bioverativ Therapeutics Recombinant Plasma Protein Therapeutics Main Business and Markets Served
Table Aptevo Therapeutics Recombinant Plasma Protein Therapeutics Production Sites and Area Served
Table Aptevo Therapeutics Recombinant Plasma Protein Therapeutics Product Introduction, Application and Specification
Table Aptevo Therapeutics Recombinant Plasma Protein Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Aptevo Therapeutics Recombinant Plasma Protein Therapeutics Production Growth Rate (2014-2019)
Table Aptevo Therapeutics Recombinant Plasma Protein Therapeutics Production Market Share (2014-2019)
Figure Aptevo Therapeutics Recombinant Plasma Protein Therapeutics Revenue Market Share (2014-2019)
Table Aptevo Therapeutics Recombinant Plasma Protein Therapeutics Main Business and Markets Served
Table Pharming Group Recombinant Plasma Protein Therapeutics Production Sites and Area Served
Table Pharming Group Recombinant Plasma Protein Therapeutics Product Introduction, Application and Specification
Table Pharming Group Recombinant Plasma Protein Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Pharming Group Recombinant Plasma Protein Therapeutics Production Growth Rate (2014-2019)
Table Pharming Group Recombinant Plasma Protein Therapeutics Production Market Share (2014-2019)
Figure Pharming Group Recombinant Plasma Protein Therapeutics Revenue Market Share (2014-2019)
Table Pharming Group Recombinant Plasma Protein Therapeutics Main Business and Markets Served
Figure Global Recombinant Plasma Protein Therapeutics Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Recombinant Plasma Protein Therapeutics Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Recombinant Plasma Protein Therapeutics Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Recombinant Plasma Protein Therapeutics Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Recombinant Plasma Protein Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Recombinant Plasma Protein Therapeutics Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Recombinant Plasma Protein Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Recombinant Plasma Protein Therapeutics Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Recombinant Plasma Protein Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Recombinant Plasma Protein Therapeutics Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Recombinant Plasma Protein Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Recombinant Plasma Protein Therapeutics Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Recombinant Plasma Protein Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Recombinant Plasma Protein Therapeutics Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Recombinant Plasma Protein Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Recombinant Plasma Protein Therapeutics by Type (2019-2025)
Table Global Consumption (K Units) of Recombinant Plasma Protein Therapeutics by Application (2019-2025)
Table Recombinant Plasma Protein Therapeutics Distributors List
Table Recombinant Plasma Protein Therapeutics Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の血漿タンパク質製品市場：専門的調査 Plasma is used as a raw material to produce a category of drugs called plasma protein products. The global Plasma Protein Products market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Plasma Pr…- 血漿タンパク質結合アッセイの世界市場：市場規模・現状・予測 Plasma Protein Binding Assay is an assay, or an analytic procedure, whose procedure or method relies on the binding of ligand molecules to receptors, antibodies or other macromolecules.[1] A detection method is used to determine the presence and extent of the ligand-receptor complexes formed, and th…
- プラズマ治療の世界市場：インサイト・予測 Plasma, pale yellow in color, is the component of the blood.To calculate the market size, the report considers revenue generated from the sales of branded therapies derived from the various fractions of plasma such as albumin, immunoglobulins, coagulation factors, hyperimmune globulins, and A1PI. Th…
- PEG化タンパク質治療薬の世界市場：市場規模・現状・予測 PEGylation is the process of covalent and non-covalent attachment of polyethylene glycol polymer chains to molecules, such as a drug, therapeutic protein, or vesicle. PEGylated protein therapeutics is estimated to show significant market growth during the forecast period, majorly due to the, growth …
- 組換え治療用抗体及びタンパク質の世界市場：インサイト・予測 Therapeutic proteins are engineered in the laboratory for pharmaceutical use, including non-covalent binders. These proteins are highly effective and serve as modernized treatment for rare as well as chronic diseases. Protein therapeutics offer custom-made treatment approach by supporting a specific…